Results 131 to 140 of about 5,773 (172)
Some of the next articles are maybe not open access.
Biofilms and vulvovaginal candidiasis
Colloids and Surfaces B: Biointerfaces, 2019Candida species, including C. albicans, are part of the mucosal flora of most healthy women, and inhabit the gastrointestinal and genitourinary tracts. Under favourable conditions, they can colonize the vulvovaginal mucosa, giving rise to symptomatic vulvovaginal candidiasis (VVC). The mechanism by which Candida spp.
Rodríguez-Cerdeira, Carmen +9 more
openaire +3 more sources
InnovAiT: Education and inspiration for general practice, 2013
Vulvovaginal candidiasis is a common condition that will, at some point, affect three-quarters of all women of reproductive age. It is caused by an overgrowth of Candida yeast. There are a number of situations that make candidiasis more likely, including pregnancy, diabetes, immunosuppression and use of antibiotics.
Adam Brocklebank, Hemant Maraj
openaire +1 more source
Vulvovaginal candidiasis is a common condition that will, at some point, affect three-quarters of all women of reproductive age. It is caused by an overgrowth of Candida yeast. There are a number of situations that make candidiasis more likely, including pregnancy, diabetes, immunosuppression and use of antibiotics.
Adam Brocklebank, Hemant Maraj
openaire +1 more source
Ibrexafungerp in the Treatment of Vulvovaginal Candidiasis
Annals of Pharmacotherapy, 2022Objective To review the pharmacology, efficacy, and safety of ibrexafungerp in the management of vulvovaginal candidiasis (VVC). Data Sources Literature was sought using PubMed (1966—February 2022) and EMBASE (1973—February 2022), and ...
Kylie N. Barnes +2 more
openaire +2 more sources
Recurrent Vulvovaginal Candidiasis
New England Journal of Medicine, 1986Recurrent vulvovaginal candidiasis (RVVC) is a common cause of significant morbidity in women in all strata of society affecting millions of women worldwide. Previously, RVVC occurrence was limited by onset of menopause but the widespread use of hormone replacement therapy has extended the at-risk period.
openaire +2 more sources
Chronic Vulvovaginal Candidiasis
New England Journal of Medicine, 2004Vulvovaginal symptoms are common, and they represent one of the most frequent reasons for visits to physicians by women in all age groups. Vulvovaginitis is rarely life-threatening, and it is therefore vastly understudied and poorly understood. However, it is associated with substantial, albeit poorly quantified, cumulative morbidity. It causes genital
openaire +2 more sources
Ibrexafungerp for the treatment of vulvovaginal candidiasis
Drugs of Today, 2022Worldwide, effective management of vulvovaginal candidiasis (VVC) continues to serve as a major therapeutic goal with numerous unmet drug treatment challenges. After 3 decades of azole drug dominance, with few recent new antifungal agents and little progress in VVC management, the first-in-class oral triterpenoid glucan synthase inhibitor agent ...
openaire +2 more sources
A serologic test for vulvovaginal candidiasis
International Journal of Gynecology & Obstetrics, 2003Vulvovaginal candidiasis (VVC) is a common medical problem affecting many women in the community w1–3x. The diagnosis of VVC remains problematic. Clinical features of VVC are nonspecific, and the standard laboratory test to identify Candida organisms from a vaginal swab may take between 5 to 7 days to confirm the diagnosis. Thus, as many as half of the
S W, Tan, A, Mackay, J, Warmington
openaire +2 more sources
Antibiotic-associated vulvovaginal candidiasis
Current Infectious Disease Reports, 2003Vulvovaginal candidiasis (VVC) is one of the most common causes of vaginitis, and its incidence has increased markedly during the past three decades. The widespread overuse of antibiotics has been suggested as one of the major factors contributing to the increasing incidence of VVC. However, evidence supporting this association has been limited because
Jinping, Xu, Jack D., Sobel
openaire +2 more sources
Clinical evidence, 2005
Vulvovaginal candidiasis is estimated to be the second most common cause of vaginitis after bacterial vaginosis. Candida albicans accounts for 85% to 90% of cases.We conducted a systematic review and aimed to answer the following clinical questions: What are the effects of drug treatments for acute vulvovaginal candidiasis in non-pregnant symptomatic ...
openaire +5 more sources
Vulvovaginal candidiasis is estimated to be the second most common cause of vaginitis after bacterial vaginosis. Candida albicans accounts for 85% to 90% of cases.We conducted a systematic review and aimed to answer the following clinical questions: What are the effects of drug treatments for acute vulvovaginal candidiasis in non-pregnant symptomatic ...
openaire +5 more sources
Vulvovaginal Candidiasis and Bacterial Vaginosis
Infectious Disease Clinics of North America, 2008Vulvovaginal candidiasis (VVC) and bacterial vaginosis (BV) are frequently encountered in clinical practice. Recent advances have furthered understanding of pathophysiology. Proper diagnosis, based on appropriate office and, in complicated cases, laboratory tests is the key to rational selection of therapy.
openaire +2 more sources